Disruption of NEUROD2 causes a neurodevelopmental syndrome with autistic features via cell-autonomous defects in forebrain glutamatergic neurons.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
11 2021
Historique:
received: 20 08 2020
accepted: 26 05 2021
revised: 17 05 2021
pubmed: 1 7 2021
medline: 15 3 2022
entrez: 30 6 2021
Statut: ppublish

Résumé

While the transcription factor NEUROD2 has recently been associated with epilepsy, its precise role during nervous system development remains unclear. Using a multi-scale approach, we set out to understand how Neurod2 deletion affects the development of the cerebral cortex in mice. In Neurod2 KO embryos, cortical projection neurons over-migrated, thereby altering the final size and position of layers. In juvenile and adults, spine density and turnover were dysregulated in apical but not basal compartments in layer 5 neurons. Patch-clamp recordings in layer 5 neurons of juvenile mice revealed increased intrinsic excitability. Bulk RNA sequencing showed dysregulated expression of many genes associated with neuronal excitability and synaptic function, whose human orthologs were strongly associated with autism spectrum disorders (ASD). At the behavior level, Neurod2 KO mice displayed social interaction deficits, stereotypies, hyperactivity, and occasionally spontaneous seizures. Mice heterozygous for Neurod2 had similar defects, indicating that Neurod2 is haploinsufficient. Finally, specific deletion of Neurod2 in forebrain excitatory neurons recapitulated cellular and behavioral phenotypes found in constitutive KO mice, revealing the region-specific contribution of dysfunctional Neurod2 in symptoms. Informed by these neurobehavioral features in mouse mutants, we identified eleven patients from eight families with a neurodevelopmental disorder including intellectual disability and ASD associated with NEUROD2 pathogenic mutations. Our findings demonstrate crucial roles for Neurod2 in neocortical development, whose alterations can cause neurodevelopmental disorders including intellectual disability and ASD.

Identifiants

pubmed: 34188164
doi: 10.1038/s41380-021-01179-x
pii: 10.1038/s41380-021-01179-x
pmc: PMC8760061
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
NEUROD2 protein, human 0
Neurod2 protein, mouse 0
Neuropeptides 0
Transcription Factors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6125-6148

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harbor Perspect Biol. 2012;4:1–22.
Rubenstein JL, Merzenich MM. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003;2:255–67.
pubmed: 14606691 pmcid: 6748642 doi: 10.1034/j.1601-183X.2003.00037.x
Fernandez F, Garner CC. Over-inhibition: a model for developmental intellectual disability. Trends Neurosci. 2007;30:497–503.
pubmed: 17825437 doi: 10.1016/j.tins.2007.07.005
Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science. 1995;268:836–44.
pubmed: 7754368 doi: 10.1126/science.7754368
McCormick MB, Tamimi RM, Snider L, Asakura A, Bergstrom D, Tapscott SJ. NeuroD2 and neuroD3: distinct expression patterns and transcriptional activation potentials within the neuroD gene family. Mol Cell Biol. 1996;16:5792–800.
pubmed: 8816493 pmcid: 231580 doi: 10.1128/MCB.16.10.5792
Lin CH, Hansen S, Wang Z, Storm DR, Tapscott SJ, Olson JM. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proc Natl Acad Sci USA. 2005;102:14877–82.
pubmed: 16203979 pmcid: 1239945 doi: 10.1073/pnas.0506785102
Wilke SA, Hall BJ, Antonios JK, Denardo LA, Otto S, Yuan B, et al. NeuroD2 regulates the development of hippocampal mossy fiber synapses. Neural Dev. 2012;7:9.
pubmed: 22369234 pmcid: 3310804 doi: 10.1186/1749-8104-7-9
Yang Y, Kim AH, Yamada T, Wu B, Bilimoria PM, Ikeuchi Y, et al. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science. 2009;326:575–8.
pubmed: 19900895 pmcid: 2846784 doi: 10.1126/science.1177087
Ince-Dunn G, Hall BJ, Hu SC, Ripley B, Huganir RL, Olson JM, et al. Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron. 2006;49:683–95.
pubmed: 16504944 doi: 10.1016/j.neuron.2006.01.031
Sega AG, Mis EK, Lindstrom K, Mercimek-Andrews S, Ji W, Cho MT, et al. De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2) cause a form of early infantile epileptic encephalopathy. J Med Genet. 2019;56:113–22.
pubmed: 30323019 doi: 10.1136/jmedgenet-2018-105322
Mis EK, Sega AG, Signer RH, Cartwright T, Ji W, Martinez-Agosto JA, et al. Expansion of NEUROD2 phenotypes to include developmental delay without seizures. Am J Med Genet A. 2021.
Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell. 2013;155:997–1007.
pubmed: 24267886 pmcid: 3995413 doi: 10.1016/j.cell.2013.10.020
Raedler TJ, Knable MB, Weinberger DR. Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol. 1998;8:157–61.
pubmed: 9568403 doi: 10.1016/S0959-4388(98)80019-6
Chen F, Moran JT, Zhang Y, Ates KM, Yu D, Schrader LA, et al. The transcription factor NeuroD2 coordinates synaptic innervation and cell intrinsic properties to control excitability of cortical pyramidal neurons. J Physiol. 2016;594:3729–44.
pubmed: 27146976 pmcid: 4929321 doi: 10.1113/JP271953
Telley L, Govindan S, Prados J, Stevant I, Nef S, Dermitzakis E, et al. Sequential transcriptional waves direct the differentiation of newborn neurons in the mouse neocortex. Science. 2016;351:1443–6.
pubmed: 26940868 doi: 10.1126/science.aad8361
Telley L, Agirman G, Prados J, Amberg N, Fièvre S, Oberst P, et al. Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. Science 2019;364:1–7.
Bayam E, Sahin GS, Guzelsoy G, Guner G, Kabakcioglu A, Ince-Dunn G. Genome-wide target analysis of NEUROD2 provides new insights into regulation of cortical projection neuron migration and differentiation. BMC Genomics. 2015;16:681.
pubmed: 26341353 pmcid: 4560887 doi: 10.1186/s12864-015-1882-9
Guzelsoy G, Akkaya C, Atak D, Dunn CD, Kabakcioglu A, Ozlu N, et al. Terminal neuron localization to the upper cortical plate is controlled by the transcription factor NEUROD2. Sci Rep. 2019;9:19697.
pubmed: 31873146 pmcid: 6927953 doi: 10.1038/s41598-019-56171-x
Feng G, Mellor RH, Bernstein M, Keller-Peck C, Nguyen QT, Wallace M, et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron. 2000;28:41–51.
pubmed: 11086982 doi: 10.1016/S0896-6273(00)00084-2
Gross GG, Junge JA, Mora RJ, Kwon HB, Olson CA, Takahashi TT, et al. Recombinant probes for visualizing endogenous synaptic proteins in living neurons. Neuron. 2013;78:971–85.
pubmed: 23791193 pmcid: 3779638 doi: 10.1016/j.neuron.2013.04.017
Larkum ME, Nevian T, Sandler M, Polsky A, Schiller J. Synaptic integration in tuft dendrites of layer 5 pyramidal neurons: a new unifying principle. Science. 2009;325:756–60.
pubmed: 19661433 doi: 10.1126/science.1171958
Benarroch EE. HCN channels: function and clinical implications. Neurology. 2013;80:304–10.
pubmed: 23319474 doi: 10.1212/WNL.0b013e31827dec42
Carr DB, Andrews GD, Glen WB, Lavin A. alpha2-Noradrenergic receptors activation enhances excitability and synaptic integration in rat prefrontal cortex pyramidal neurons via inhibition of HCN currents. J Physiol. 2007;584:437–50.
pubmed: 17702809 pmcid: 2277172 doi: 10.1113/jphysiol.2007.141671
Isshiki M, Tanaka S, Kuriu T, Tabuchi K, Takumi T, Okabe S. Enhanced synapse remodelling as a common phenotype in mouse models of autism. Nat Commun. 2014;5:4742.
pubmed: 25144834 doi: 10.1038/ncomms5742
Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet. 2011;20:3093–108.
pubmed: 21558424 pmcid: 3131048 doi: 10.1093/hmg/ddr212
Kim H, Kunz PA, Mooney R, Philpot BD, Smith SL. Maternal loss of Ube3a impairs experience-driven dendritic spine maintenance in the developing visual cortex. J Neurosci. 2016;36:4888–94.
pubmed: 27122043 pmcid: 4846678 doi: 10.1523/JNEUROSCI.4204-15.2016
Klingler E, Francis F, Jabaudon D, Cappello S. Mapping the molecular and cellular complexity of cortical malformations. Science 2021;371:1–9.
Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci. 2010;11:490–502.
pubmed: 20559336 pmcid: 3087436 doi: 10.1038/nrn2851
Olson JM, Asakura A, Snider L, Hawkes R, Strand A, Stoeck J, et al. NeuroD2 is necessary for development and survival of central nervous system neurons. Dev Biol. 2001;234:174–87.
pubmed: 11356028 doi: 10.1006/dbio.2001.0245
Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci. 2002;22:6309–14.
pubmed: 12151506 pmcid: 6758181 doi: 10.1523/JNEUROSCI.22-15-06309.2002
Bindea G, Mlecnik B, Hackl H, Charoentong P, Tosolini M, Kirilovsky A, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–3.
pubmed: 19237447 pmcid: 2666812 doi: 10.1093/bioinformatics/btp101
Pereanu W, Larsen EC, Das I, Estevez MA, Sarkar AA, Spring-Pearson S, et al. AutDB: a platform to decode the genetic architecture of autism. Nucleic Acids Res. 2017:1–6.
Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell. 2011;146:247–61.
pubmed: 21784246 pmcid: 3232425 doi: 10.1016/j.cell.2011.06.013
van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities. Annu Rev Genet. 2011;45:81–104.
pubmed: 21910631 doi: 10.1146/annurev-genet-110410-132512
Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
doi: 10.1038/nature13595
Pirooznia M, Wang T, Avramopoulos D, Valle D, Thomas G, Huganir RL, et al. SynaptomeDB: an ontology-based knowledgebase for synaptic genes. Bioinformatics. 2012;28:897–9.
pubmed: 22285564 pmcid: 3307115 doi: 10.1093/bioinformatics/bts040
Li M, Santpere G, Imamura Kawasawa Y, Evgrafov OV, Gulden FO, Pochareddy S, et al. Integrative functional genomic analysis of human brain development and neuropsychiatric risks. Science 2018;362:1–13.
Sanders SJ, He X, Willsey AJ, Ercan-Sencicek AG, Samocha KE, Cicek AE, et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron. 2015;87:1215–33.
pubmed: 26402605 pmcid: 4624267 doi: 10.1016/j.neuron.2015.09.016
Study DDD. Prevalence and architecture of de novo mutations in developmental disorders. Nature. 2017;542:433–8.
doi: 10.1038/nature21062
Cross-Disorder Group of the Psychiatric Genomics C. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371–9.
doi: 10.1016/S0140-6736(12)62129-1
Krishnan A, Zhang R, Yao V, Theesfeld CL, Wong AK, Tadych A, et al. Genome-wide prediction and functional characterization of the genetic basis of autism spectrum disorder. Nat Neurosci. 2016;19:1454–62.
pubmed: 27479844 pmcid: 5803797 doi: 10.1038/nn.4353
Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.
pubmed: 24487276 pmcid: 3992975 doi: 10.1038/ng.2892
Farah MH, Olson JM, Sucic HB, Hume RI, Tapscott SJ, Turner DL. Generation of neurons by transient expression of neural bHLH proteins in mammalian cells. Development. 2000;127:693–702.
pubmed: 10648228 doi: 10.1242/dev.127.4.693
Fong AP, Yao Z, Zhong JW, Cao Y, Ruzzo WL, Gentleman RC, et al. Genetic and epigenetic determinants of neurogenesis and myogenesis. Dev Cell. 2012;22:721–35.
pubmed: 22445365 pmcid: 3331915 doi: 10.1016/j.devcel.2012.01.015
Fong AP, Yao Z, Zhong JW, Johnson NM, Farr GH, Maves L, et al. Conversion of MyoD to a neurogenic factor: binding site specificity determines lineage. Cell Rep. 2015;10:1937–46.
pubmed: 25801030 pmcid: 4683018 doi: 10.1016/j.celrep.2015.02.055
Ruzzo EK, Pérez-Cano L, Jung JY, Wang LK, Kashef-Haghighi D, Hartl C, et al. Inherited and de novo genetic risk for autism impacts shared networks. Cell. 2019;178:850–66. e826.
pubmed: 31398340 pmcid: 7102900 doi: 10.1016/j.cell.2019.07.015
Lu H, Ash RT, He L, Kee SE, Wang W, Yu D, et al. Loss and gain of MeCP2 cause similar hippocampal circuit dysfunction that is rescued by deep brain stimulation in a rett syndrome mouse model. Neuron. 2016;91:739–47.
pubmed: 27499081 pmcid: 5019177 doi: 10.1016/j.neuron.2016.07.018
Han K, Holder JL, Schaaf CP, Lu H, Chen H, Kang H, et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature. 2013;503:72–7.
pubmed: 24153177 pmcid: 3923348 doi: 10.1038/nature12630
Heng JI, Nguyen L, Castro DS, Zimmer C, Wildner H, Armant O, et al. Neurogenin 2 controls cortical neuron migration through regulation of Rnd2. Nature. 2008;455:114–8.
pubmed: 18690213 doi: 10.1038/nature07198
Young-Pearse TL, Bai J, Chang R, Zheng JB, LoTurco JJ, Selkoe DJ. A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference. J Neurosci. 2007;27:14459–69.
pubmed: 18160654 pmcid: 6673432 doi: 10.1523/JNEUROSCI.4701-07.2007
Yang T, Sun Y, Zhang F, Zhu Y, Shi L, Li H, et al. POSH localizes activated Rac1 to control the formation of cytoplasmic dilation of the leading process and neuronal migration. Cell Rep. 2012;2:640–51.
pubmed: 22959435 doi: 10.1016/j.celrep.2012.08.007
Nicole O, Bell DM, Leste-Lasserre T, Doat H, Guillemot F, Pacary E. A novel role for CAMKIIbeta in the regulation of cortical neuron migration: implications for neurodevelopmental disorders. Mol Psychiatry. 2018;23:2209–26.
pubmed: 29712998 pmcid: 6129389 doi: 10.1038/s41380-018-0046-0
Lu HC, Tan Q, Rousseaux MW, Wang W, Kim JY, Richman R, et al. Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans. Nat Genet. 2017;49:527–36.
pubmed: 28288114 pmcid: 5374026 doi: 10.1038/ng.3808
Bormuth I, Yan K, Yonemasu T, Gummert M, Zhang M, Wichert S, et al. Neuronal basic helix-loop-helix proteins Neurod2/6 regulate cortical commissure formation before midline interactions. J Neurosci. 2013;33:641–51.
pubmed: 23303943 pmcid: 6704922 doi: 10.1523/JNEUROSCI.0899-12.2013
Liston C, Gan WB. Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc Natl Acad Sci USA. 2011;108:16074–9.
pubmed: 21911374 pmcid: 3179117 doi: 10.1073/pnas.1110444108
Brown SM, Henning S, Wellman CLMild. short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb Cortex. 2005;15:1714–22.
pubmed: 15703248 doi: 10.1093/cercor/bhi048
van Weert L, Buurstede JC, Mahfouz A, Braakhuis PSM, Polman JAE, Sips HCM, et al. NeuroD factors discriminate mineralocorticoid from glucocorticoid receptor DNA binding in the male rat brain. Endocrinology. 2017;158:1511–22.
pubmed: 28324065 doi: 10.1210/en.2016-1422
Packard M, Jokhi V, Ding B, Ruiz-Canada C, Ashley J, Budnik V. Nucleus to synapse nesprin1 railroad tracks direct synapse maturation through RNA localization. Neuron. 2015;86:1015–28.
pubmed: 25959729 pmcid: 4657559 doi: 10.1016/j.neuron.2015.04.006
Rathje M, Waxman H, Benoit M, Tammineni P, Leu C, Loebrich, S et al. Genetic variants in the bipolar disorder risk locus SYNE1 that affect CPG2 expression and protein function. Mol Psychiatry. 2019:1–16.
Lehman A, Thouta S, Mancini GMS, Naidu S, van Slegtenhorst M, McWalter K, et al. Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy. Am J Hum Genet. 2017;101:65–74.
pubmed: 28669405 pmcid: 5501867 doi: 10.1016/j.ajhg.2017.05.016
Lorincz A, Nusser Z. Molecular identity of dendritic voltage-gated sodium channels. Science. 2010;328:906–9.
pubmed: 20466935 pmcid: 3546315 doi: 10.1126/science.1187958
Chi XX, Nicol GD. Manipulation of the potassium channel Kv1.1 and its effect on neuronal excitability in rat sensory neurons. J Neurophysiol. 2007;98:2683–92.
pubmed: 17855588 doi: 10.1152/jn.00437.2007
Niday Z, Tzingounis AV. Potassium channel gain of function in epilepsy: an unresolved paradox. Neuroscientist. 2018;24:368–80.
pubmed: 29542386 pmcid: 6045440 doi: 10.1177/1073858418763752
Santoro B, Piskorowski RA, Pian P, Hu L, Liu H, Siegelbaum SA. TRIP8b splice variants form a family of auxiliary subunits that regulate gating and trafficking of HCN channels in the brain. Neuron. 2009;62:802–13.
pubmed: 19555649 pmcid: 2720631 doi: 10.1016/j.neuron.2009.05.009
Piskorowski R, Santoro B, Siegelbaum SA. TRIP8b splice forms act in concert to regulate the localization and expression of HCN1 channels in CA1 pyramidal neurons. Neuron. 2011;70:495–509.
pubmed: 21555075 pmcid: 3107038 doi: 10.1016/j.neuron.2011.03.023
Caubit X, Gubellini P, Andrieux J, Roubertoux PL, Metwaly M, Jacq B, et al. TSHZ3 deletion causes an autism syndrome and defects in cortical projection neurons. Nat Genet. 2016;48:1359–69.
pubmed: 27668656 pmcid: 5083212 doi: 10.1038/ng.3681
Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474:337–42.
pubmed: 21677750 pmcid: 3572410 doi: 10.1038/nature10163
Chen F, Hall BJ. Synaptic activity suppresses expression of neurogenic differentiation factor 2 in an NMDA receptor-dependent manner. Synapse 2017;71:1–11.
Pieper A, Rudolph S, Wieser GL, Gotze T, Miessner H, Yonemasu T, et al. NeuroD2 controls inhibitory circuit formation in the molecular layer of the cerebellum. Sci Rep. 2019;9:1448.
pubmed: 30723302 pmcid: 6363755 doi: 10.1038/s41598-018-37850-7
de Chevigny A, Core N, Follert P, Gaudin M, Barbry P, Beclin C, et al. miR-7a regulation of Pax6 controls spatial origin of forebrain dopaminergic neurons. Nat Neurosci. 2012;15:1120–6.
pubmed: 22729175 doi: 10.1038/nn.3142
Stringer C, Wang T, Michaelos M, Pachitariu M. Cellpose: a generalist algorithm for cellular segmentation. Nat Methods. 2021;18:100–6.
pubmed: 33318659 doi: 10.1038/s41592-020-01018-x
Phillip JM, Han KS, Chen WC, Wirtz D, Wu PH. A robust unsupervised machine-learning method to quantify the morphological heterogeneity of cells and nuclei. Nat Protoc. 2021;16:754–74.
pubmed: 33424024 pmcid: 8167883 doi: 10.1038/s41596-020-00432-x
Wearne SL, Rodriguez A, Ehlenberger DB, Rocher AB, Henderson SC, Hof PR. New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple scales. Neuroscience. 2005;136:661–80.
pubmed: 16344143 doi: 10.1016/j.neuroscience.2005.05.053
Yu G, Wang LG, He QY. ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics. 2015;31:2382–3.
pubmed: 25765347 doi: 10.1093/bioinformatics/btv145
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–21.
pubmed: 23104886 doi: 10.1093/bioinformatics/bts635
Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol. 2010;28:511–5.
pubmed: 20436464 pmcid: 3146043 doi: 10.1038/nbt.1621
Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923–30.
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303

Auteurs

Karen Runge (K)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Rémi Mathieu (R)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Stéphane Bugeon (S)

IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Sahra Lafi (S)

INMED, INSERM, Aix-Marseille University, Marseille, France.
IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Corinne Beurrier (C)

IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Surajit Sahu (S)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Fabienne Schaller (F)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Arthur Loubat (A)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Leonard Herault (L)

TAGC INSERM U1090, Aix-Marseille University, Marseille, France.

Stéphane Gaillard (S)

Phenotype Expertise, 5 Boulevard du Maréchal Koenig, Marseille, France.

Emilie Pallesi-Pocachard (E)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Aurélie Montheil (A)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Andreas Bosio (A)

Miltenyi Biotec, Bergisch-Gladbach, Germany.

Jill A Rosenfeld (JA)

Baylor College of Medicine, Houston, TX, USA.

Eva Hudson (E)

Cook Children's Clinical Genetics, Fort Worth, TX, USA.

Kristin Lindstrom (K)

Division of genetics and Metabolism, Phoenix Children's Hospital, Phoenix, AZ, USA.

Saadet Mercimek-Andrews (S)

Department of Medical Genetics, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB, Canada.

Lauren Jeffries (L)

Pediatric Genomics Discovery Program, Department of Pediatrics, Yale University School of Medicine, New Haven, CT, USA.

Arie van Haeringen (A)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.

Olivier Vanakker (O)

Center for Medical Genetics, Department of Biomolecular Medicine, Ghent University and Ghent University Hospital, Ghent, Belgium.

Audrey Van Hecke (A)

Department of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Université Libre de Bruxelles (ULB), Brussels, Belgium.

Dina Amrom (D)

Department of Neurology, Queen Fabiola Children's University Hospital, Brussels, Belgium.
Université Libre de Bruxelles (ULB), Brussels, Belgium.
Neuropediatric Unit, Kannerklinik, Centre Hospitalier de Luxembourg, Luxembourg, Grand-Duchy of Luxembourg, Luxembourg, Luxembourg.

Sebastien Küry (S)

Centre Hospitalier Universitaire de Nantes, Service de Génétique Médicale, Nantes, France.
INSERM, CNRS, UNIV Nantes, l'institut du thorax, Nantes, France.

Chana Ratner (C)

Hackensack University Medical Center, Hackensack, NJ, USA.

Reena Jethva (R)

Hackensack University Medical Center, Hackensack, NJ, USA.

Candace Gamble (C)

Cook Children's Clinical Genetics, Fort Worth, TX, USA.

Bernard Jacq (B)

IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Laurent Fasano (L)

IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Gabriel Santpere (G)

Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.

Belen Lorente-Galdos (B)

Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.

Nenad Sestan (N)

Department of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine, New Haven, CT, USA.

Antoinette Gelot (A)

Trousseau Hospital, Paris, France.

Sylvie Giacuzz (S)

Trousseau Hospital, Paris, France.

Sandra Goebbels (S)

Max-Planck-Institute of Experimental Medicine, Goettingen, Germany.

Alfonso Represa (A)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Carlos Cardoso (C)

INMED, INSERM, Aix-Marseille University, Marseille, France.

Harold Cremer (H)

IBDM, Aix-Marseille University, CNRS, UMR, Marseille, France.

Antoine de Chevigny (A)

INMED, INSERM, Aix-Marseille University, Marseille, France. antoine.de-chevigny@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH